Home / Fact sheets / Nicaragua / Cervical quantitative data
Country fact sheet: Nicaragua (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |||
Population (personally invited) | ||||||||||||||
Target population | 310623 | 299322 | 261101 | 237489 | 194846 | 158518 | 130777 | 113398 | 96771 | 69524 | 111368 | 1 983 737 | ||
Annual target population | 310 623 | 299 322 | 261 101 | 237 489 | 194 846 | 158 518 | 130 777 | 113 398 | 96 771 | 69 524 | 0 | 0 | 111 368 | 1 983 737 |
Women invited | 41392 | 123972 | 153560 | 137995 | 112731 | 91601 | 44450 | 38198 | 14448 | 10398 | 16479 | 785 224 | ||
Invitation coverage (%) | 13.3 | 41.4 | 58.8 | 58.1 | 57.9 | 57.8 | 34.0 | 33.7 | 14.9 | 15.0 | 0.0 | 0.0 | 14.8 | 39.6 |
Examinations (All tests in the year) | ||||||||||||||
Women screened | 120 418 | 124 280 | 85 150 | 96 819 | 78 575 | 68 468 | 39 017 | 35 516 | 21 253 | 12 476 | 0 | 0 | 8 228 | 690 200 |
Examination coverage rate (%) | 38.8 | 41.5 | 32.6 | 40.8 | 40.3 | 43.2 | 29.8 | 31.3 | 22.0 | 17.9 | 0.0 | 0.0 | 7.4 | 34.8 |
Result (All tests in the year) | ||||||||||||||
Positive | 4 374 | 4 330 | 3 666 | 3 633 | 2 544 | 2 409 | 1 645 | 1 058 | 667 | 522 | 0 | 0 | 316 | 25 164 |
Negative | 112 436 | 115 806 | 77 686 | 90 011 | 73 153 | 63 544 | 35 408 | 32 550 | 19 188 | 10 954 | 0 | 0 | 7 103 | 637 839 |
Unknown | 3 608 | 4 144 | 3 798 | 3 175 | 2 878 | 2 515 | 1 964 | 1 908 | 1 398 | 1 000 | 0 | 0 | 809 | 27 197 |
Referral for further assessment (%) | 3.6 | 3.5 | 4.3 | 3.8 | 3.2 | 3.5 | 4.2 | 3.0 | 3.1 | 4.2 | 0.0 | 0.0 | 3.8 | 0.0 |
Further assessment (all positive) | ||||||||||||||
Done | 1 600 | 1 965 | 1 760 | 2 009 | 1 637 | 1 355 | 918 | 647 | 399 | 258 | 0 | 0 | 227 | 12 775 |
Not done | 2 774 | 2 365 | 1 906 | 1 624 | 907 | 1 054 | 727 | 411 | 268 | 264 | 0 | 0 | 89 | 12 389 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Further assessment participation rate (%) | 36.6 | 45.4 | 48.0 | 55.3 | 64.3 | 56.2 | 55.8 | 61.2 | 59.8 | 49.4 | 0.0 | 0.0 | 71.8 | 50.8 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carcinoma | 5 | 11 | 28 | 74 | 65 | 79 | 69 | 62 | 44 | 33 | 0 | 0 | 59 | 529 |
CIN3 / Adenocarcinoma in situ (CGIN) | 26 | 58 | 89 | 92 | 70 | 60 | 40 | 20 | 14 | 15 | 0 | 0 | 16 | 500 |
CIN2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 1 569 | 1 896 | 1 643 | 1 843 | 1 502 | 1 216 | 809 | 565 | 341 | 210 | 0 | 0 | 152 | 11 746 |